2023 Q1 Form 10-Q Financial Statement

#000143774923012481 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $76.27M $89.72M
YoY Change -14.99% 141.87%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.01M $12.54M
YoY Change 3.71% 29.82%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.083M $3.868M
YoY Change 5.56% -24.04%
% of Gross Profit
Operating Expenses $17.09M $16.43M
YoY Change 4.02% -12.59%
Operating Profit $82.13M $73.29M
YoY Change 12.07% 299.29%
Interest Expense $2.853M $9.387M
YoY Change -69.61% -5.88%
% of Operating Profit 3.47% 12.81%
Other Income/Expense, Net $9.387M
YoY Change -5.88%
Pretax Income $79.28M $63.90M
YoY Change 24.06% 662.43%
Income Tax
% Of Pretax Income
Net Earnings $79.28M $63.90M
YoY Change 24.06% 662.43%
Net Earnings / Revenue 103.94% 71.22%
Basic Earnings Per Share
Diluted Earnings Per Share $3.10 $3.170M
COMMON SHARES
Basic Shares Outstanding 12.63M 12.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.66M $135.6M
YoY Change -86.98% 40.12%
Cash & Equivalents $17.66M $135.6M
Short-Term Investments
Other Short-Term Assets $3.216M $3.510M
YoY Change -8.38% 16.19%
Inventory
Prepaid Expenses
Receivables $36.51M $32.73M
Other Receivables $0.00 $0.00
Total Short-Term Assets $57.38M $171.8M
YoY Change -66.6% 48.5%
LONG-TERM ASSETS
Property, Plant & Equipment $432.4M $458.0M
YoY Change -5.59% -3.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $295.4M $280.2M
YoY Change 5.43% 7.22%
Other Assets $7.622M $5.528M
YoY Change 37.88% -17.22%
Total Long-Term Assets $778.3M $790.5M
YoY Change -1.54% -0.38%
TOTAL ASSETS
Total Short-Term Assets $57.38M $171.8M
Total Long-Term Assets $778.3M $790.5M
Total Assets $835.7M $962.3M
YoY Change -13.16% 5.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.452M $1.896M
YoY Change -23.42% 37.89%
Accrued Expenses $3.466M $3.388M
YoY Change 2.3% -30.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $39.06M $39.05M
YoY Change 0.02% 0.01%
Total Short-Term Liabilities $52.68M $68.21M
YoY Change -22.78% 5.48%
LONG-TERM LIABILITIES
Long-Term Debt $133.8M $378.2M
YoY Change -64.61% -9.12%
Other Long-Term Liabilities $6.124M $4.803M
YoY Change 27.5% 1.54%
Total Long-Term Liabilities $139.9M $383.0M
YoY Change -63.46% -9.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.68M $68.21M
Total Long-Term Liabilities $139.9M $383.0M
Total Liabilities $231.5M $490.3M
YoY Change -52.79% -8.59%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $604.2M $472.0M
YoY Change
Total Liabilities & Shareholders Equity $835.7M $962.3M
YoY Change -13.16% 5.84%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $79.28M $63.90M
YoY Change 24.06% 662.43%
Depreciation, Depletion And Amortization $4.083M $3.868M
YoY Change 5.56% -24.04%
Cash From Operating Activities $72.90M $52.33M
YoY Change 39.31% 125.56%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $699.0K $0.00
YoY Change -100.0%
Cash From Investing Activities $697.0K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $89.70M $16.70M
YoY Change 437.2% 0.01%
Cash From Financing Activities -$95.03M -$52.26M
YoY Change 81.84% 94.84%
NET CHANGE
Cash From Operating Activities $72.90M $52.33M
Cash From Investing Activities $697.0K $0.00
Cash From Financing Activities -$95.03M -$52.26M
Net Change In Cash -$21.44M $70.00K
YoY Change -30722.86% -102.32%
FREE CASH FLOW
Cash From Operating Activities $72.90M $52.33M
Capital Expenditures $2.000K $0.00
Free Cash Flow $72.90M $52.33M
YoY Change 39.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
202501
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
202501
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
250000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
250000
CY2023Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2023Q1 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1850
CY2022Q4 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1850
CY2023Q1 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
12634642
CY2023Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
12634642
CY2022Q4 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
12505996
CY2022Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
12505996
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2022Q4 nrp Discount Rate
DiscountRate
0.15 pure
CY2022Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2023Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
6700000 usd
CY2022Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
7500000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18717000 usd
CY2023Q1 us-gaap Partners Capital
PartnersCapital
470899000 usd
CY2022Q4 us-gaap Partners Capital
PartnersCapital
477457000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
835668000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
877131000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19254000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14837000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q1 nrp Revenue Net Including Gain Loss On Disposition Of Assets
RevenueNetIncludingGainLossOnDispositionOfAssets
99219000 usd
CY2022Q1 nrp Revenue Net Including Gain Loss On Disposition Of Assets
RevenueNetIncludingGainLossOnDispositionOfAssets
89716000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
7163000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
8076000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3868000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5845000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4467000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
17091000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
16430000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
82128000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
73286000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2853000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
9387000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
63899000 usd
CY2023Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
6661000 usd
CY2022Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
7500000 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16228000 usd
CY2022Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
-0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
56386000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
56399000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55258000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55271000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-1128000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-1128000 usd
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.40
CY2022Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.45
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.44
CY2022Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.11
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
63899000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19583000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2545000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
59692000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
66444000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
477457000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2023Q1 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
-16228000 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
40900000 usd
CY2023Q1 nrp Decrease For Distributions To Unitholders
DecreaseForDistributionsToUnitholders
8086000 usd
CY2023Q1 nrp Partners Capital Account Unitbased Compensation Amortization
PartnersCapitalAccountUnitbasedCompensationAmortization
-1178000 usd
CY2023Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
142000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19583000 usd
CY2023Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
470899000 usd
CY2021Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
256024000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
63899000 usd
CY2022Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
5672000 usd
CY2022Q1 nrp Decrease For Distributions To Unitholders
DecreaseForDistributionsToUnitholders
7758000 usd
CY2022Q1 nrp Partners Capital Account Unitbased Compensation Amortization
PartnersCapitalAccountUnitbasedCompensationAmortization
-1754000 usd
CY2022Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
112000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2545000 usd
CY2022Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
307396000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
63899000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3868000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10780000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
13230000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19254000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14837000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-610000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1028000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2491000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1448000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
25000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
375000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7061000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7579000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-541000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-60000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8805000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7156000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
263000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
7250000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-154000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7316000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1618000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1838000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
72900000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52331000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
101000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
598000 usd
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
0 usd
CY2023Q1 dei Entity File Number
EntityFileNumber
001-31465
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2164875
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1415 Louisiana Street, Suite 3325
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
697000 usd
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
94200000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
89696000 usd
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16697000 usd
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2023Q1 dei City Area Code
CityAreaCode
713
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
48085000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
-0 usd
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
751-7507
CY2023Q1 dei Security12b Title
Security12bTitle
Common Units representing limited partner interests
CY2023Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
-0 usd
CY2023Q1 dei Trading Symbol
TradingSymbol
NRP
CY2022Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
19579000 usd
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3052000 usd
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47964000 usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-866000 usd
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17655000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39091000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36513000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42701000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3216000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1822000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
57384000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
83614000 usd
CY2023Q1 us-gaap Land
Land
24008000 usd
CY2022Q4 us-gaap Land
Land
24008000 usd
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
408371000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
412312000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14613000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14713000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
295361000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
306470000 usd
CY2023Q1 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
28309000 usd
CY2022Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
28946000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7622000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7068000 usd
CY2023Q1 us-gaap Assets
Assets
835668000 usd
CY2022Q4 us-gaap Assets
Assets
877131000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1452000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1992000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3466000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11916000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1252000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
989000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7450000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6256000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
39055000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
39076000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
52675000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60229000 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
38833000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40181000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
133821000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
129205000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6124000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5472000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
231453000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
235087000 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
133316000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
164587000 usd
CY2023Q1 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
417401000 usd
CY2022Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
404799000 usd
CY2023Q1 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
6400000 usd
CY2022Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
5977000 usd
CY2023Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47964000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2813000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95033000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52261000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21436000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
70000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39091000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
135520000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17655000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
135590000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2474000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1644000 usd
CY2023Q1 nrp Number Of Wholly Owned Operating Companies
NumberOfWhollyOwnedOperatingCompanies
1 pure
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76271000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71083000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
46437000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
61862000 usd
CY2023Q1 nrp Deferred Revenue Contractual Minimum Payments
DeferredRevenueContractualMinimumPayments
7770000 usd
CY2022Q1 nrp Deferred Revenue Contractual Minimum Payments
DeferredRevenueContractualMinimumPayments
5059000 usd
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
7924000 usd
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
12375000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
46283000 usd
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
54546000 usd
CY2022Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.45
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12570
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12415
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Preferred Units
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfPreferredUnits
3778
CY2022Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Preferred Units
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfPreferredUnits
6974
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
56607000 usd
CY2023Q1 nrp Preferred Units Number Of Redeemed Units
PreferredUnitsNumberOfRedeemedUnits
-47499
CY2023Q1 nrp Redemption Of Preferred Units
RedemptionOfPreferredUnits
-31271000 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16200000 usd
CY2023Q1 nrp Preferred Units Number Of Redeemed Units
PreferredUnitsNumberOfRedeemedUnits
47499
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55258000 usd
CY2022Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55271000 usd
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12570
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12415
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.40
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Warrants
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfWarrants
1255
CY2022Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Warrants
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfWarrants
531
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Unit Awards
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfUnitAwards
209
CY2022Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Unit Awards
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfUnitAwards
240
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
17812
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
20160
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
63899000 usd
CY2023Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
586000 usd
CY2022Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
-0 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16228000 usd
CY2022Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
-0 usd
CY2023Q1 nrp Net Income Loss Allocated To General Partners And Limited Partners Diluted
NetIncomeLossAllocatedToGeneralPartnersAndLimitedPartnersDiluted
62461000 usd
CY2022Q1 nrp Net Income Loss Allocated To General Partners And Limited Partners Diluted
NetIncomeLossAllocatedToGeneralPartnersAndLimitedPartnersDiluted
63899000 usd
CY2023Q1 nrp Income Loss Attributable To Parent And Other Income From Warrant Liability Fair Value Adjustments Allocated To General Partner
IncomeLossAttributableToParentAndOtherIncomeFromWarrantLiabilityFairValueAdjustmentsAllocatedToGeneralPartner
-1249000 usd
CY2022Q1 nrp Income Loss Attributable To Parent And Other Income From Warrant Liability Fair Value Adjustments Allocated To General Partner
IncomeLossAttributableToParentAndOtherIncomeFromWarrantLiabilityFairValueAdjustmentsAllocatedToGeneralPartner
-1278000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
61212000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
62621000 usd
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.44
CY2022Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.11
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q1 nrp Revenues Excluding Gain On Sale Of Asset
RevenuesExcludingGainOnSaleOfAsset
99123000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7163000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5845000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2853000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
79275000 usd
CY2022Q1 nrp Revenues Excluding Gain On Sale Of Asset
RevenuesExcludingGainOnSaleOfAsset
89716000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8076000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3868000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4467000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
19000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
9387000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
63899000 usd
CY2023Q1 us-gaap Mineral Properties Gross
MineralPropertiesGross
695966000 usd
CY2023Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
287595000 usd
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
408371000 usd
CY2022Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
695971000 usd
CY2022Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
283659000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
412312000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
173591000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
169087000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
715000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
806000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
172876000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
168281000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
39055000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
39076000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
133821000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
129205000 usd
CY2023Q1 nrp Discount Rate
DiscountRate
0.15 pure
CY2023Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-600000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1000000.0 usd
CY2023Q1 nrp Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
15900000 usd
CY2022Q1 nrp Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
7900000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
20200000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6300000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
386000
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
28.96
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
278000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
56.94
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
184000
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
26.30
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
480000
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
46.20
CY2023Q1 nrp Shortterm Receivables Gross
ShorttermReceivablesGross
42410000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3874000 usd
CY2023Q1 nrp Shortterm Receivables Net Of Cecl Allowance
ShorttermReceivablesNetOfCeclAllowance
38536000 usd
CY2022Q4 nrp Shortterm Receivables Gross
ShorttermReceivablesGross
47237000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4461000 usd
CY2022Q4 nrp Shortterm Receivables Net Of Cecl Allowance
ShorttermReceivablesNetOfCeclAllowance
42776000 usd
CY2023Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
29325000 usd
CY2023Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1016000 usd
CY2023Q1 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
28309000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
29984000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1038000 usd
CY2022Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
28946000 usd
CY2023Q1 nrp Total Receivables Gross
TotalReceivablesGross
71735000 usd
CY2023Q1 nrp Cecl Allowance Total
CECLAllowanceTotal
4890000 usd
CY2023Q1 nrp Total Receivables Net Of Cecl Allowance
TotalReceivablesNetOfCeclAllowance
66845000 usd
CY2022Q4 nrp Total Receivables Gross
TotalReceivablesGross
77221000 usd
CY2022Q4 nrp Cecl Allowance Total
CECLAllowanceTotal
5499000 usd
CY2022Q4 nrp Total Receivables Net Of Cecl Allowance
TotalReceivablesNetOfCeclAllowance
71722000 usd

Files In Submission

Name View Source Status
nrp-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nrp-20230331_lab.xml Edgar Link unprocessable
0001437749-23-012481-index-headers.html Edgar Link pending
0001437749-23-012481-index.html Edgar Link pending
0001437749-23-012481.txt Edgar Link pending
0001437749-23-012481-xbrl.zip Edgar Link pending
ex_466593.htm Edgar Link pending
ex_466594.htm Edgar Link pending
ex_466595.htm Edgar Link pending
ex_466596.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nrp-20230331.xsd Edgar Link pending
nrp20220630_10qimg001.jpg Edgar Link pending
nrp20230331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
nrp20230331_10q_htm.xml Edgar Link completed
nrp-20230331_def.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nrp-20230331_pre.xml Edgar Link unprocessable